InvestorsHub Logo
icon url

daBoze

09/08/14 1:45 PM

#98275 RE: JG36 #98271

If these flucides are that difficult to make, how did they make enough for 6000 animal tests?
icon url

drkazmd65

09/08/14 1:50 PM

#98277 RE: JG36 #98271

18 months of not producing enough Flucide for tox is what make me doubtful



As the results of the non-GLP studies conducted at KARD were not announced as completed until December 2013 - it has not been anywhere near 18 months since the finalized quantities of Flucide that would be needed to send to BASi were known. The 18 month figure you tout is inaccurate.

http://www.nanoviricides.com/press%20releases/2013/NanoViricides%20Inc%20Reports%20Excellent%20Safety%20Profile%20of%20Its%20Broad%20Spectrum%20anti%20Influenza%20Drug%20Candidate%20FluCide%20in%20a%20Non%20GLP%20Study.html

Note - Date of December 2, 2013. 9 Months ago.

After NNVC knew that they'd need large quantities of Flucide for tox testing (which should have come as no surprise, since BK's been assuring us for years that the stuff is as practically as safe as water) we were still told that the existing lab was sufficient to make the Flucide for tox



The existing lab is sufficient to make the Flucide for TOX - it's just suboptimal as the scale of production possible in the old facility is quite a bit lower than the scale of production that will be routine once the new plant is Validated. Because the old facility is sub-optimal, and because the quantities needed are higher than initially expected - it has taken a while.

Now they're flailing about trying to get the process working in their new facility. So far, no kilograms of Flucide from that source either.



What evidence is there that work validating the new plant is anything but on schedule? What evidence do you have that there is ANY 'flailing around' going on there other than your unsubstantiated opinion?

I just think these nanoviricides are proving to be a lot harder to make than Dr. Seymour has been willing to admit.



Possibly,... but that's just opinion as well.